1-9 of 9
A. Osterborg
Close
Sort by
Journal Articles

HuMax-CD4 (Zanolimumab), a Fully Human Monoclonal Antibody: Early Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphoma of Non-Cutaneous Type.

Francesco d’Amore, T. Relander, H. Hagberg, A. Osterborg, M. Hansen, L. Moeller, P. Johnson, J. Radford, B. Hancock, M. Gramatzki, S. Krause, M. Dreyling, N. Schmitz, S. Lisby, O. Baadsgaard
Journal: Blood
Blood (2005) 106 (11): 3354.
https://doi.org/10.1182/blood.V106.11.3354.3354
Published: 2005
Journal Articles

Treatment of Refractory Autoimmune Hemolytic Anemia in B-CLL with Alemtuzumab (Humanized CD52 MAb).

Jeanette Lundin, F. Celsing, C. Karlsson, A. Osterborg
Journal: Blood
Blood (2005) 106 (11): 2967.
https://doi.org/10.1182/blood.V106.11.2967.2967
Published: 2005
Journal Articles

Virus Reactivation Profile as Assessed by PCR and Serology Pattern Following First-Line Alemtuzumab (Anti-CD52 Monoclonal Antibody, Campath®) Therapy in Patients with B-CLL.

C. Karlsson, H. Dahl, A. Linde, J. Lundin, M. Björkholm, H. Mellstedt, A. Osterborg
Journal: Blood
Blood (2004) 104 (11): 968.
https://doi.org/10.1182/blood.V104.11.968.968
Published: 2004
Journal Articles

Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma--a randomized multicenter study. The European Study Group of Erythropoietin (Epoetin Beta) Treatment in Multiple Myeloma and Non-Hodgkin's Lymphoma

A Osterborg, MA Boogaerts, R Cimino, U Essers, J Holowiecki, G Juliusson, G Jager, A Najman, D Peest
Journal: Blood
Blood (1996) 87 (7): 2675–2682.
https://doi.org/10.1182/blood.V87.7.2675.bloodjournal8772675
Published: 1996
Journal Articles

Idiotype-reactive T-cell subsets and tumor load in monoclonal gammopathies

Q Yi, A Osterborg, S Bergenbrant, H Mellstedt, G Holm, AK Lefvert
Journal: Blood
Blood (1995) 86 (8): 3043–3049.
https://doi.org/10.1182/blood.V86.8.3043.3043
Published: 1995
Journal Articles

Induction of anti-recombinant human granulocyte-macrophage colony- stimulating factor (Escherichia coli-derived) antibodies and clinical effects in nonimmunocompromised patients

P Ragnhammar, HJ Friesen, JE Frodin, AK Lefvert, M Hassan, A Osterborg, H Mellstedt
Journal: Blood
Blood (1994) 84 (12): 4078–4087.
https://doi.org/10.1182/blood.V84.12.4078.bloodjournal84124078
Published: 1994
Journal Articles

Natural interferon-alpha in combination with melphalan/prednisone versus melphalan/prednisone in the treatment of multiple myeloma stages II and III: a randomized study from the Myeloma Group of Central Sweden

A Osterborg, M Bjorkholm, M Bjoreman, G Brenning, K Carlson, F Celsing, G Gahrton, G Grimfors, H Gyllenhammar, R Hast
Journal: Blood
Blood (1993) 81 (6): 1428–1434.
https://doi.org/10.1182/blood.V81.6.1428.1428
Published: 1993
Journal Articles

Establishment of idiotype bearing B-lymphocyte clones from a patient with monoclonal gammopathy

A Osterborg, M Steinitz, N Lewin, S Bergenbrant, G Holm, AK Lefvert, H Mellstedt
Journal: Blood
Blood (1991) 78 (10): 2642–2649.
https://doi.org/10.1182/blood.V78.10.2642.2642
Published: 1991
Journal Articles

Predominant T cell receptor V gene usage in patients with abnormal clones of B cells

CH Janson, J Grunewald, A Osterborg, H DerSimonian, MB Brenner, H Mellstedt, H Wigzell
Journal: Blood
Blood (1991) 77 (8): 1776–1780.
https://doi.org/10.1182/blood.V77.8.1776.1776
Published: 1991